Clinical Trial Update: Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of recombinant factor VIII for severe or moderately severe Hemophilia A. The current status of the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant Factor VIII (Factor VIII, recombinant)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Hemophilia A | Phase 3 | Status: UNKNOWN